Zusammenfassung
Amrmon (Inocor)
-
1.
ist ein Katesholamin
-
2.
ist ein Glykosid
-
3.
wirkt nur parenteral
-
4.
erniedrigt den Wedgedruck (PAWP)
-
5.
erhöht den cAMP-Spiegel
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Lawson NW (1989) Use of inotropes and vasopressors. ASA Annual Refresher
Course Lectures, New Orleans, 421 Parmley WW (1987) Medical treatment of CHF: where are we now? Circulation IV: 4–10
Rutman HI, LeJemtel TH, Sonnenblick EH (1987) Newer cardiotonic agents: implications for patients with heart failure and ischaemic heart disease. J Cardiothor Anesth:59–70 Smith TW (1988) Digitalis: mechanism of action and clinical use. New Engl J Med: 358–365
Stoelting RK (1987) Pharmakology and physiology in anesthetic practice. Lippincott, Philadelphia, pp 267, 269–279
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Petroianu, G., Osswald, P.M. (1991). Amrinon. In: Anästhesie in Frage und Antwort. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05717-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-662-05717-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53842-4
Online ISBN: 978-3-662-05717-9
eBook Packages: Springer Book Archive